Sigma Investment Counselors Inc Bristol Myers Squibb CO Transaction History

Sigma Investment Counselors Inc

  • $1.69 Billion
  • Q4 2024

A detailed history of Sigma Investment Counselors Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Sigma Investment Counselors Inc holds 35,591 shares of BMY stock, worth $2.02 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
35,591
Previous 34,476 3.23%
Holding current value
$2.02 Million
Previous $1.78 Million 12.84%
% of portfolio
0.12%
Previous 0.09%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 03, 2025
BUY
$51.92 - $59.94 $57,890 - $66,833
1,115 Added 3.23%
35,591 $2.01 Million
Q3 2024

Oct 23, 2024
SELL
$39.66 - $51.75 $121,676 - $158,769
-3,068 Reduced 8.17%
34,476 $1.78 Million
Q2 2024

Jul 25, 2024
SELL
$40.25 - $52.99 $1.28 Million - $1.68 Million
-31,702 Reduced 45.78%
37,544 $1.56 Million
Q1 2024

Apr 25, 2024
SELL
$47.98 - $54.4 $93,561 - $106,080
-1,950 Reduced 2.74%
69,246 $3.76 Million
Q4 2023

Jan 22, 2024
BUY
$48.48 - $57.85 $218,402 - $260,614
4,505 Added 6.76%
71,196 $3.65 Million
Q3 2023

Oct 23, 2023
SELL
$57.89 - $64.73 $123,016 - $137,551
-2,125 Reduced 3.09%
66,691 $3.87 Million
Q2 2023

Jul 21, 2023
SELL
$63.71 - $70.74 $20,323 - $22,566
-319 Reduced 0.46%
68,816 $4.4 Million
Q1 2023

Apr 28, 2023
BUY
$65.71 - $74.53 $7,556 - $8,570
115 Added 0.17%
69,135 $4.79 Million
Q4 2022

Jan 27, 2023
SELL
$68.48 - $81.09 $34,376 - $40,707
-502 Reduced 0.72%
69,020 $0
Q3 2022

Oct 24, 2022
SELL
$0.13 - $76.84 $117 - $69,232
-901 Reduced 1.28%
69,522 $4.94 Million
Q2 2022

Jul 15, 2022
BUY
$72.62 - $79.98 $29,846 - $32,871
411 Added 0.59%
70,423 $5.42 Million
Q1 2022

Apr 20, 2022
BUY
$61.48 - $73.72 $15,738 - $18,872
256 Added 0.37%
70,012 $5.11 Million
Q4 2021

Feb 08, 2022
SELL
$53.63 - $62.52 $81,034 - $94,467
-1,511 Reduced 2.12%
69,756 $4.35 Million
Q3 2021

Nov 05, 2021
BUY
$59.17 - $69.31 $36,034 - $42,209
609 Added 0.86%
71,267 $4.22 Million
Q2 2021

Aug 04, 2021
SELL
$61.91 - $67.42 $78,563 - $85,555
-1,269 Reduced 1.76%
70,658 $4.72 Million
Q1 2021

Apr 30, 2021
SELL
$59.34 - $66.74 $87,526 - $98,441
-1,475 Reduced 2.01%
71,927 $4.54 Million
Q4 2020

Feb 04, 2021
BUY
$57.74 - $65.43 $2.02 Million - $2.29 Million
34,993 Added 91.11%
73,402 $4.55 Million
Q3 2020

Oct 20, 2020
SELL
$57.43 - $63.64 $2.19 Million - $2.42 Million
-38,084 Reduced 49.79%
38,409 $2.32 Million
Q2 2020

Jul 31, 2020
BUY
$54.82 - $64.09 $297,562 - $347,880
5,428 Added 7.64%
76,493 $4.5 Million
Q1 2020

Apr 22, 2020
BUY
$46.4 - $67.43 $7,331 - $10,653
158 Added 0.22%
71,065 $3.96 Million
Q4 2019

Jan 21, 2020
BUY
$49.21 - $64.19 $1.06 Million - $1.38 Million
21,467 Added 43.42%
70,907 $4.55 Million
Q3 2019

Oct 18, 2019
BUY
$42.77 - $50.71 $337,925 - $400,659
7,901 Added 19.02%
49,440 $2.51 Million
Q2 2019

Jul 23, 2019
SELL
$44.62 - $49.34 $262,856 - $290,661
-5,891 Reduced 12.42%
41,539 $1.88 Million
Q1 2019

Apr 26, 2019
SELL
$45.12 - $53.8 $8,392 - $10,006
-186 Reduced 0.39%
47,430 $2.26 Million
Q4 2018

Feb 01, 2019
SELL
$48.76 - $63.23 $260,670 - $338,027
-5,346 Reduced 10.09%
47,616 $2.48 Million
Q3 2018

Oct 23, 2018
BUY
$55.19 - $62.25 $34,493 - $38,906
625 Added 1.19%
52,962 $3.29 Million
Q2 2018

Jul 24, 2018
SELL
$50.53 - $62.98 $7,933 - $9,887
-157 Reduced 0.3%
52,337 $2.9 Million
Q1 2018

Apr 30, 2018
SELL
$59.92 - $68.98 $26,244 - $30,213
-438 Reduced 0.83%
52,494 $3.32 Million
Q4 2017

Feb 08, 2018
BUY
$59.94 - $65.35 $37,042 - $40,386
618 Added 1.18%
52,932 $3.24 Million
Q3 2017

Nov 06, 2017
BUY
$55.23 - $63.74 $2.89 Million - $3.33 Million
52,314
52,314 $3.33 Million

Others Institutions Holding BMY

# of Institutions
2,639
Shares Held
1.46B
Call Options Held
31.5M
Put Options Held
34.9M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $121B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Sigma Investment Counselors Inc Portfolio

Follow Sigma Investment Counselors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sigma Investment Counselors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Sigma Investment Counselors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email